We are currently recruiting patients with Palmoplantar Pustulosis (PPP). This study investigates the Efficacy and safety of ANB019.

Updated on 22 December 2020
skin disorder
skin disease


The study drug consists of a sub-cutaneous investigational treatment or a placebo, that will be administered on Day 1, followed by 3 doses of the study treatment on Days 29, Day 57 and Day 85.

Several blood samples will be collected throughout the study. Your participation in the biopsy portion of the study is optional. During the study visits, a physical evaluation of your Palmoplantar Pustulosis and overall health will be done with the study team. 

This study will last a period of up to 6 months and includes up to 18 visits; Visits take approximately 1 to 5 hours each. The screening visit may take up to 3 hours.

Compensation for time and travel may be available. There will be no cost to you for taking part in this study. You will be provided with all study medication, examinations and medical care related to the study at no cost to you.



Visit our website for more information: www.pustulardermstudies.com

Condition Skin Infections/Disorders, Psoriasis and Psoriatic Disorders, Skin Conditions, Dermatology Psoriasis Psoriatic Disorders Palmoplantar Pustulosis
Clinical Study IdentifierTX239014
Last Modified on22 December 2020


Yes No Not Sure

Inclusion Criteria

Between 18 and 75 years old?
Suffering from Palmoplantar Pustulosis?
Have had Palmoplantar Pustulosis for at least 3 months? If not since at least one month?
Currently have active pustules on palms or/and soles?
BMI between 18 and 36 kg/m2?
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note